
- Volume 0 0
Company Is Honored for Its Commitment
On May 8, 2004, Novo Nordisk received the Angel Award for its dedication to improving the lives of individuals with diabetes and its unwavering focus on treating and preventing diabetes worldwide. The award was presented at the Los Angeles Chapter of the Juvenile Diabetes Research Foundation's (JDRF) annual gala benefiting the Stem Cell Research Fund.
Along with its work with the JDRF, Novo Nordisk is active in a number of initiatives as part of the company's dedication to social responsibility. The company recently launched the Diabetes Aware campaign with the Entertainment Industry Foundation to educate Americans about the importance of detection, monitoring, and proper management of this chronic, progressive disease.
Articles in this issue
almost 22 years ago
Bloodstream Infection Risk Is Higher for Diabeticsalmost 22 years ago
Research Links Diabetes with Alzheimer'salmost 22 years ago
Individuals with Chronic Pain Keep Quietalmost 22 years ago
Association Redesigns Web Sitealmost 22 years ago
Fibromyalgia Hits Individuals Differentlyalmost 22 years ago
Procedure May Relieve Agony of Spinal Cord Injuriesalmost 22 years ago
Europeans Are Slow to Seek Treatmentalmost 22 years ago
Intervention Curbs Asthma in Childrenalmost 22 years ago
Vaccine at Birth May Diminish Allergiesalmost 22 years ago
Asthma in Women Is Greater with Acetaminophen Use





































































































































